GlassScriptPhysician profile
Albert Cua Chan
NPI 1891800405
$3,363.17
in general payments reported to CMS, 2019-2025
21 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $1,012 · 2021: $348 · 2022: $589 · 2023: $710 · 2024: $103 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872 · Education: $64.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.24 |
| Education | $64.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $876.00 | 2020 | |
| Abbvie INC. | $574.97 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $421.35 | 2019-2025 | Tyblume, Slynd |
| Medtronic, INC. | $256.94 | 2022-2023 | Truclear |
| Amarin Pharma, INC. | $241.19 | 2019 | |
| Therapeuticsmd, INC. | $209.29 | 2020-2022 | |
| Abiomed | $134.42 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Ofev |
| Daiichi Sankyo INC. | $125.00 | 2021 | |
| Myovant Sciences INC. | $69.79 | 2021-2022 | |
| Pfizer INC. | $53.82 | 2023-2024 | |
| Avion Pharmaceuticals | $53.63 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $48.34 | 2025 | Myfembree |
| Millicent US INC | $45.00 | 2025 | |
| Hologic Sales and Service, LLC | $27.95 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $25.00 | 2019 | |
| Aspira Women'S Health INC | $21.69 | 2019 | |
| Ethicon US, LLC | $19.58 | 2022 | |
| Coopersurgical, INC. | $14.98 | 2024 | Summit Doppler |
| Amag Pharmaceuticals, INC. | $12.38 | 2019 | |
| Organon LLC | $6.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.